← All trials
NCT04315025
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 7, 2018
- Primary completion
- Jun 20, 2019
- Completion date
- Sep 20, 2019
- First posted
- Mar 19, 2020
- Last posted
- Mar 26, 2020
- Enrollment
- 18
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Prodia StemCell IndonesiaLead sponsor
- Gadjah Mada UniversityOverall official - principal investigator
- Gadjah Mada UniversityStudy director
- Gadjah Mada UniversityStudy chair
- Prodia StemCell IndonesiaStudy director
- Prodia StemCell IndonesiaStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.